Academic Press Advances in Clinical Chemistry: Volume 106

Product Description Advances in Clinical Chemistry, Volume 106, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, with this new release focusing on Advances in ADAMTS biomarkers, Advances in fibrosis biomarkers in nonalcoholic fatty liver disease, Metabolomics of Peripheral Artery Disease, Molecular and cellular functions of long non-coding RNAS in prostate and breast cancer, Myostatin: Basic Biology to Clinical Application, and Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer. Review Publishes cutting-edge reviews in the field of clinical chemistry that include the expertise of international contributors About the Author Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.